(Reuters) -Eli Lilly and Co said on Thursday it had received a subpoena from the U.S. Department of Justice related to its New Jersey plant that makes its COVID-19 treatment, bamlanivimab. Eli Lilly and Company (NYSE: LLY) has struck a deal with MiNA Therapeutics to develop small activating RNA (saRNA) candidates against up to five targets across its key therapeutic focus areas LLY Eli Lilly and Co Eli Lilly Accelerates Baricitinib Availability in India Amid Covid-19 Surge By Colin Kellaher Eli Lilly & Co. on Tuesday said it is donating hundreds of thousands of doses of baricitinib to the Indian government, as the nation of more than 1.3 billion people grappl... Foresight Autonomous Holdings Ltd (NASDAQ: FRSX) CFO Eli Yoresh and VP of business development Doron Cohadier appeared on Benzinga's YouTube show "Power Hour" for an exclusive interview Tuesday Terns Pharmaceuticals Inc., a biopharmaceutical startup backed by Eli Lilly & Co., on Tuesday said it raised $87 million in a Series C funding round at an undisclosed valuation. Terns said Deerfield Management Co. led the round, alongside an equity investment by Eli Lilly. OrbiMed Advisors, Lilly Asia Ventures, Vivo Capital, Samsara Capital MSN Labs has entered into a royalty-free, non-exclusive, voluntary license agreement with the US-based Eli Lilly and Co for manufacturing and marketing of baricitinib in India.
[index]